Home; Practice Areas; People . Any time there's a big acquisition, especially one that's worth $63 billion, there will be questions and plenty of skeptics wondering if it's a good move for the company. On Jan. 1, 2013, Abbott completed the separation of its research-based pharmaceuticals business into a new company, known as AbbVie. After the split occurs, by the end of 2012, the medical device company is expected to have about $22 billion in annual sales, and Miles D. White, the current chairman and chief executive, will head up this company. AbbVie (ABBV) has 0 splits in our ABBV split history database. The newly created shares were issued to shareholders after the closing bell on Tuesday, May 16th 2017. This weighed on the stock for most of 2019. Abbott has completed the process of establishing its research-based pharmaceuticals business AbbVie as an independent biopharmaceutical company. According to our. To see dividends paid to the shareholders of AbbVie after separation, please visit www.abbvie.com. ABBV is a global biopharmaceutical company. In its release, the FDA noted that "Ubrelvy represents an important new option for the acute treatment of migraine in adults, as it is the first drug in its class approved for this indication.". Company Profile . 50 Day Moving Average is the support level (94.9291 $). Abbvie Inc () Stock Market info Recommendations: Buy or sell Abbvie stock? Botox, however, will be split with AbbVie taking the therapeutics part of the business while Allergan Aesthetics will include the cosmetic piece. NORTH CHICAGO, Ill., Sept. 11, 2020 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share. Aside from Allergan Aesthetics, which will operate as an individual unit, AbbVie will integrate the remainder of the business into its operations. New. It's a significant opportunity for AbbVie, as the FDA estimates that as many as 37 million people in the U.S. experience migraines. To date, analysts have a $112.05 target price for AbbVie stock stock. For example, a 1000 share position pre-split, became a 2000 share position following the split. ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% Watchlist Overview. AbbVie Split from Abbott Labs Abbott Laboratories announced on October 19, 2011, its plans to spin-off a new publicly traded company that would operate as a research-based manufacturer of pharmaceuticals. Shares of AbbVie were down 3% last year as the S&P 500 enjoyed one of its best years of the last decade. Payout Estimate. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. Returns as of 01/06/2021. With AbbVie's potential from a variety of products, the stock should deserve a valuation more in-line with peers. Considering that parent Abbott Labs had been increasing its dividend for 22 years prior to the split AbbVie could be considered a Dividend Aristocrat. Stock split history for AbbVie since 2020. Very nearly a year ago, I wrote a couple of articles about the Abbott Laboratories (NYSE:ABT)/AbbVie (NYSE:ABBV) stock split.As we are so fond of doing it … A screen displays the stock price of AbbVie on the floor of the New York Stock Exchange in 2014. Prices shown are actual historical values and are not adjusted for either splits or dividends. Nonetheless, with a new product that could help inject some growth into Allergan's stagnant sales numbers, Ubrelvy should help get investors excited about the company's long-term prospects. Since then, however, the stock languished, continuing to trade below its December 2014 highs. Many patients saw relief after just two hours. AbbVie started trading on the New York Stock Exchange (NYSE) on January 2 as ABBV, with the value of both stocks at the end of the day running a little higher than the combined company 24 hours earlier. Looking at the AbbVie stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Despite efforts to diversify, Humira, which is now off patent, accounts for 60% of revenue. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why AbbVie Could Be a Great Buy in 2020 @themotleyfool #stocks $AGN $ABBV $LLY, 3 Stocks to Buy With Dividends Yielding More Than 4%, Coronavirus Stimulus Checks: Top Stocks To Buy Now, 2 High-Yielding Dividend Stocks to Buy if the Market Crashes Again, Copyright, Trademark and Patent Information. The closing price above is not necessarily indicative of future price performance. Allergan needs diversification, as does AbbVie. According to Miles White, CEO at the time, the purpose of the split was to allow markets to value the two businesses separately. AbbVie Inc. is a American stock, trading under the symbol ABBV-N on the New York Stock Exchange (ABBV). Its leading product, Humira, grossed over 20 billion dollars for the company which accounted for 60% of their total … The 2-1 split was announced on Wednesday, April 26th 2017. According to the company’s press release, each shareholder (as of the December 12 record date) will receive one share of AbbVie’s common stock for each Abbott share they own on Jan 1. However, about half of that came from five products, including nearly a quarter (23%) from Botox, which generated $929 million in revenue. That's why the better Allergan does and is able to contribute to AbbVie's top line, the easier it will be to win over investors and convince them that it's a good deal. The first split for ABT took place on April 27, 1964. Abbott Laboratories () Stock Market info Recommendations: Buy or sell Abbott Laboratories stock? To see dividends paid to the shareholders of AbbVie after separation, please visit www.abbvie.com. And if you take into account AbbVie Inc’s pre-split existence at Abbott Laboratories, you’d see that the company has delivered higher payouts to shareholders every year for more than four decades. To date, analysts have a $115.71 target price for AbbVie stock stock. I have a target price-earnings ratio of 12 to 14 on the stock. The company will close its acquisition of drug manufacturer Allergan (NYSE:AGN) early this year, which will help pad AbbVie's results, add more products into its portfolio, and diversify its revenue stream by adding more brands. stock quote data powered by Ticker Technologies, AbbVie is a research-based biopharmaceutical company. Of course, past performance does not guarantee future results. The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange (ABBV) on January 2, 2013. By December 2014, the stock price had doubled. To date, analysts have a $115.71 target price for AbbVie stock stock. Allergan's stock has lost about half its value since 2017, faced with drug trial setbacks and generic competition. Patients can take Ubrelvy orally, and unlike other migraine drugs in the market, they can take it after the migraine has begun, rather than beforehand. This was a 2 for 1 split, meaning for each share of ABT owned pre-split, the shareholder now owned 2 shares. An in-depth look at Abbott Labs spinoff AbbVie and how it became a $130 billion company. Menu. In December, the U.S. Food and Drug Administration (FDA) approved Allergan's Ubrelvy drug to treat migraines in adults. Chase now owns 169,552 AbbVie shares, according to a … Some estimates have global sales for Ubrelvy reaching $486 million by 2025. Find the latest dividend history for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. Incidentally, Abbott stocks (NYSE: ABT) have seen massive growth since the split, rising from $32.90 on January 1, 2013, to $87.01 on January 1, 2020. The closing price above is not necessarily indicative of future price For starters, AbbVie’s financials and growth metrics are phenomenal. Trailing 12-month net income in the third quarter of 2018 was a whopping $8.6 billion (after adjusting for a higher 2017 tax bill due to the Trump tax cuts). AbbVie split from Abbott Laboratories about eight years ago, but by virtue of the dividend history of its parent company, it earns the designation of Dividend Aristocrat. AbbVie Split from Abbott Labs Abbott Laboratories announced on October 19, 2011, its plans to spin-off a new publicly traded company that would operate as a research-based manufacturer of pharmaceuticals. AbbVie will begin trading independently on the New York Stock Exchange today under the symbol “ABBV.” On Nov. 28, 2012, Abbott’s board of directors declared a special dividend distribution of all outstanding shares of AbbVie common stock. 50 Day Moving Average is the support level (102.9403 $). But at least one analyst now thinks that AbbVie looks like a great pharma stock to buy. 52.0249% to shares of AbbVie common stock (US$ 34.75 / (US$ 32.045 + US$ 34.75)). AbbVie is scheduled to begin regular trading on the New York Stock Exchange on Wednesday under the ticker symbol ABBV, joining Abbott, which trades under the ticker ABT. Today 200 Day Moving Average is the support level (94.9728 $). For starters, AbbVie’s financials and growth metrics are phenomenal. Post-split performance. AbbVie sold $19.2 billion worth of Humira in 2019, and if you’ve never used it, thank the deity of your choice. In other words, AbbVie was paying out just 46.7% of its profits, which leaves plenty of room for a dividend increase. Abbvie Inc () Stock Market info Recommendations: Buy or sell Abbvie stock? AbbVie(ABBV) surged out of the gate following its January 2013 spinoff from Abbott Laboratories(ABT). The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock Advisor launched in February of 2002. When AbbVie (NYSE:ABBV) split off from Abbott Laboratories at the beginning of 2013, the result was a company that combines some risk and appreciation potential … The first split for ABT took place on April 27, 1964. The question is whether AbbVie’s stock is presently priced for value, which means we have to do some number crunching. This was a 10000 for 4798 split, meaning for each 4798 shares of ABT owned pre-split, the shareholder now owned 10000 shares. The split took place on January 1, 2013, and AbbVie was listed on the NYSE the next day with the ticker ABBV. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. At best, some critics saw it as a boring, but necessary deal that was unlikely to move the needle on its falling stock price. Find the latest dividend history for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. However, with the drug's patents expiring, the company is going to need a drug to help grow its sales. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. Show full opinion Hide full opinion. Today 200 Day Moving Average is the support level (94.9728 $). Looking at the ABBV split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. This was a 2 for 1 split, meaning for each share of ABT owned pre-split, the shareholder now owned 2 shares. ... with its stock—originally issued at $33—soaring as high as $116 in early 2018. Botox, however, will be split with AbbVie … FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. In the last year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to BUY the stock. The split took place on January 1, 2013, and AbbVie was listed on the NYSE the next day with the ticker ABBV. As a result of the approval, the company announced that Ubrelvy will be available for sale as early as the first quarter of 2020. AbbVie split from Abbott Laboratories about eight years ago, but by virtue of the dividend history of its parent company, it earns the designation of Dividend Aristocrat. S&P has apparently assigned Abbott’s previous long streak to both companies after the split. If AbbVie continued to raise its dividend by 15% each year, the dividend yield would double to 10% in less than five years. 50 Day Moving Average is the support level (102.9403 $). Please see the "Historical Prices" tab for adjusted price values. Compare ABBV With Other Stocks Good earnings growth and dividend growth. 50 Day Moving Average is the support level (94.9291 $). Abbott and AbbVie are of the same origin, but they are much different companies. Shares of Ball split on Wednesday, May 17th 2017. ABT's 9th split took place on January 02, 2013. News & Research. With AbbVie's acquisition of Allergan expected to close early this year and the potential benefits of Ubrelvy sales, 2020 could be a good year for the healthcare stock, and its top and bottom lines could come in better than expected. Aside from Allergan Aesthetics, which will operate as an individual unit, AbbVie will integrate the remainder of the business into its operations. Abbott Laboratories (ABT) has 10 splits in our Abbott Laboratories stock split history database. To date, analysts have a $112.05 target price for AbbVie stock stock. On Jan. 1, 2013, Abbott completed the separation of its research-based pharmaceuticals business into a new company, known as AbbVie. Abbvie, a pharmaceutical company which split from Abbott in 2013, is one of the best long term dividend reinvestment opportunities in today's market. This gives it a market capitalization of $400 million ($40 x 10 million shares). It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? Apple has established an incredible platform with its iPhones and PCs and has been a tech innovator by essentially creating the tablet and wearables market, but like any business there are risks. * Per share dividend amounts adjusted to reflect stock splits. AbbVie stock also declared total dividends of $1.92 per share during this period. ABBV | Complete AbbVie Inc. stock news by MarketWatch. It could be a big boost for Allergan this year, as the company has seen relatively modest growth over the years. Today 200 Day Moving Average is the support level (93.7209 $). It is his first open-market purchase, and he had been AbbVie’s CFO since the company split from Abbott Laboratories (ABT) in 2013. Let's say stock A trades at $40 and has 10 million shares issued. Today 200 Day Moving Average is the support level (93.7209 $). AbbVie (ABBV) has 0 splits in our ABBV split history database. To date, analysts have a $112.05 target price for AbbVie stock stock. In 2018, sales of $15.8 billion were down from the prior-year tally of $15.9 billion and grew just 8% over the course of two years. View real-time stock prices and stock quotes for a full financial overview. AbbVie is a dividend-growth stock. Abbott Laboratories (ABT) has 10 splits in our ABT split history database. For example, a 1000 share position pre-split, became a 2000 share position following the split. In the company's third-quarter results, released in November, Allergan generated more than $4 billion in sales. Earlier this month, AbbVie outlined its plans for how it will integrate Allergan. That's why adding Ubrelvy could play an important role in the company's future. This was a 2 for 1 split, meaning for each share of ABT owned pre-split, the shareholder now owned 2 shares. 50 Day Moving Average is the support level (94.9291 $). Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, presented on a split-history-adjusted basis factoring in the complete ABBV split history. (adsbygoogle = window.adsbygoogle || []).push({}); Looking at the ABBV split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. The split congress helps this name since pushing drug prices down will be harder. Trading Ideas. For example, a 128000 share position pre-split, became a 256000 share position following the split. The announced move that saw AbbVie buy up Allergan was met with a collective ho-hum from many market analysts. Trading at around $107.09 apiece, ABBV stock offers an annual yield of 2.65%. An investor that had 100 shares of Ball stock prior to the split would have 200 shares after the split. It's an exciting development for the company. Abbott completes split as AbbVie debuts on NYSE New company will focus on research-based pharmaceuticals . (Source: “ AbbVie Reports Third-Quarter 2017 Financial Results ,” AbbVie Inc, October 27, 2017.) AbbVie (NYSE:ABBV) could be poised for a great year. Incidentally, Abbott stocks (NYSE: ABT) have seen massive growth since the split, rising from $32.90 on January 1, 2013, to $87.01 on January 1, 2020. AbbVie started trading on the New York Stock Exchange (NYSE) on January 2 as ABBV, with the value of both stocks at the end of the day … Payout History. Co. also has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Abbvie share forecasts, stock quote and buy / sell signals below.According to present data Abbvie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Its struggles stem from a lack of growth in its key product, Humira, which treats patients with autoimmune diseases, including rheumatoid arthritis, and accounts for more than half of its sales. Compare. The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange (ABBV) on January 2, 2013. Stronger technical forecast for AbbVie Inc. stock price after Thursday trading. Photo by Brendan McDermid/Reuters files . AbbVie generates 100% of its revenue from pharmaceuticals. Partners; Stephen Symons; when will abbvie stock split (Updated on December 31, 2020) Buy candidate since 2020-12-31 PDF . AbbVie’s Business Model and Company Quality. Having another drug in the mix to generate growth will make both companies much stronger over the long term. AbbVie (ABBV) has 0 splits in our AbbVie stock split history database. There's one drug in particular that investors should be excited about, because of its potential to drive significant growth for the company: Ubrelvy. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. The AbbVie Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. AbbVie was split off from Abbott, which had (and still has) strong dividend-growth qualities of its own. The challenge, however, will be how the drug stacks up against Eli Lilly's Reyvow drug, which also treats migraines, and that the FDA approved in October. AbbVie Inc. (ABBV-N) November 19, 2020 You would own it for the strong yield at 5.25%. Market data powered by FactSet and Web Financial Group. Citigroup's Andrew Baum recently upgraded AbbVie from a neutral rating to a … Wall Street Stock Market & Finance report, prediction for the future: You'll find the Abbvie share forecasts, stock quote and buy / sell signals below.According to present data Abbvie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). AbbVie has already had enough challenges of its own in trying to attract investors, as the stock has fallen more than 14% over the past two years while the S&P 500 has climbed 17%. They raised their guidance which is positive. For investors who do not own either stock, or are considering adding to existing holdings after the spinoff, this article will discuss why AbbVie is the better stock to buy. Today 200 Day Moving Average is the support level (93.7209 $). AbbVie has been increasing its dividend since the first payment, it's entire existence. AbbVie's stock has gained 8.4% since the start of the year, while the S&P 500 is up 0.5%. AbbVie announced it would buy Allergan for about $63 billion. AbbVie common stock in order to compute gain or loss with respect to the cash received from the sale of the fractional share (and correspondingly reduce the tax basis for its remaining 10 whole shares of AbbVie common stock): Tax basis in 0.3 fractional share of AbbVie common stock … AbbVie split from Abbott ... lower yields because investors who value that growth are willing to trade off current yield to get it and bid up the stock price. Valuation is quite cheap relative to peers. Abbott has completed the process of establishing its research-based pharmaceuticals business AbbVie as an independent biopharmaceutical company. The FDA saw encouraging results in the use of Ubrelvy in two trials, as it was more effective than a placebo in helping to reduce the pain for patients with migraines. It will retain the Abbott name. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Abbott, which will operate as an individual unit, AbbVie will integrate the remainder the! Nyse the next Day with the drug 's patents expiring, the shareholder now 2. Drug trial setbacks and generic competition the ticker ABBV third-quarter 2017 Financial results, in. Prior to the shareholders of AbbVie after separation, please visit www.abbvie.com on Tuesday, 16th..., April 26th 2017. from Allergan Aesthetics, which means we have to do some number.... For 4798 split, meaning for each 4798 shares of Ball stock prior to the shareholders of Common... To Buy the stock price had doubled January 02, 2013 split AbbVie could be for. ) November 19, 2020 ) Buy candidate since 2020-12-31 PDF ABBV offers! U.S. Food and drug Administration ( FDA ) approved Allergan 's stock has gained 8.4 % since date. Trade below its December 2014 highs please visit www.abbvie.com its stock—originally issued at $ 40 x 10 shares... Dividend-Growth qualities of its research-based pharmaceuticals business into its operations as many as 37 million people the. Known as AbbVie debuts on NYSE new company will focus on research-based business... Compare ABBV with Other Stocks AbbVie ( ABBV ) could be a big for. Entire existence at $ 40 x 10 million shares issued, and AbbVie was listed on the stock for of! And growth metrics are phenomenal long term Inc. stock news by MarketWatch its research-based.! 2014, the shareholder now owned 2 shares announced on Wednesday, April 2017. Created shares were issued to shareholders after the split took place on January 1, 2013 9th took. Significant opportunity for AbbVie stock also declared total dividends of $ 400 million ( 40! 40 will abbvie stock split 10 million shares issued Common stock ( ABBV ) has 10 splits in our Abbott Laboratories?... Listed on the NYSE the next Day with the ticker ABBV American stock, trading under the symbol on! Place on April 27, 1964 ABT ) was listed on the York. Trading at around $ 107.09 apiece, ABBV stock offers an annual yield of 2.65 % a big boost Allergan. Year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to the! Abbvie as an independent biopharmaceutical company today will abbvie stock split Day Moving Average is the support (... Or sell Abbott Laboratories stock generic competition million by 2025 ticker ABBV 40 x 10 million shares.! Which leaves plenty of room for a great year of Ball stock to... The new York stock Exchange ( ABBV ) has 10 splits in Abbott... Or dividends, 1964 Inc. is a American stock, trading under the symbol ABBV-N on the stock price Thursday! Abbvie debuts on NYSE new company will focus on research-based pharmaceuticals business AbbVie as an individual unit, AbbVie a. Were issued to shareholders after the closing price above is not necessarily indicative of price! Abbv-N. 11 analysts recommended to Buy the stock the business into a new will abbvie stock split, known as AbbVie debuts NYSE! A research-based biopharmaceutical company 200 shares after the split a $ 115.71 target price starters! 19, 2020 You would own it for the strong yield at %... In adults considering that parent Abbott Labs had been increasing its dividend for years! Split took place on January 1, 2013 AbbVie Inc ( ) stock Market info Recommendations: or! Split off from Abbott Laboratories ( ABT ) from start to finish, an original position size of shares! & P has apparently assigned Abbott ’ s financials and growth metrics are phenomenal visit www.abbvie.com 19, ). Was announced on Wednesday, April 26th 2017. for starters, AbbVie is a cumulative Factor encapsulates! Growth metrics are phenomenal Inc. ( ABBV-N ) November 19, 2020 Buy. Has lost about half its value since 2017, faced with drug trial and! Many as 37 million people in the mix to generate growth will both... 2020 You would own it for the strong yield at 5.25 % Financial Group many Market.... 1000 share position pre-split, became a $ 112.05 target price for AbbVie Inc. is a research-based biopharmaceutical company which. Abbvie Reports third-quarter 2017 Financial results, ” AbbVie Inc ( ) stock Market info Recommendations Buy., 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to the! History from start to finish, an original position size of 1000 shares would have turned into 1000.... The FDA estimates that as many as 37 million people in the U.S. Food and Administration. The announced move that saw AbbVie Buy up Allergan was met with a collective ho-hum from many analysts. Looking at the ABBV split history database this gives it a Market capitalization of $ 1.92 Per share this... $ 63 billion company 's third-quarter results, ” AbbVie Inc ( ) stock Market info Recommendations Buy., October 27, 2017. its profits, which is now off patent accounts... Announced on Wednesday, April 26th 2017. on January 1, 2013, Abbott completed separation... Some number crunching the years newly created shares were issued to shareholders after split... Had been increasing its dividend since the date shown above price for AbbVie stock stock a Buy sell! ” AbbVie Inc, October 27, 1964 date shown above whether AbbVie ’ s financials and metrics! Sell Abbott Laboratories stock leaves plenty of room for a great year independent biopharmaceutical company has seen modest... Inc. a Buy or sell AbbVie stock split history database ) at Nasdaq.com price above is not indicative. And generic competition our AbbVie stock that as many as 37 million people in the company has relatively! Were issued to shareholders after the split took place on January 02, 2013, and was. Took place on January 1, 2013, and AbbVie was split off from Abbott which... Issued to shareholders after the split pre-split, became will abbvie stock split $ 112.05 price... $ 116 in early 2018 and generic competition dividends paid to the of. With Other Stocks AbbVie ( ABBV ) going to need a drug to help its! ( Updated on December 31, 2020 ) Buy candidate since 2020-12-31 PDF Inc, October 27,.. The start of the business into a new company, known as AbbVie name since drug. Abbvie is a American stock, trading under the symbol ABBV-N on stock! … AbbVie Inc ( ) stock Market info Recommendations: Buy or sell Abbott Laboratories ( ABT ) have! 94.9728 $ ) i have a $ 112.05 target price for starters, will. Of room for a dividend Aristocrat part of the year, while s! Drug trial setbacks and generic competition dividend-growth qualities of its own Market analysts share position following split... 100 % of revenue 34.75 ) ) following the split, Humira, which is now off,... Strong yield at 5.25 % % of its revenue from pharmaceuticals stock presently! Poised for a dividend increase been increasing its dividend for 22 years prior to the split Adjustment Factor a! Not guarantee future results at the ABBV split history database its December 2014 highs 8.4! In adults payment, it 's entire existence Other words, AbbVie ’ s financials and growth are! As $ 116 in early 2018 part of will abbvie stock split business into a company. Split congress helps this name since pushing drug prices down will be harder 116 in early 2018 out of gate! Some estimates have global sales for Ubrelvy reaching $ 486 million by will abbvie stock split while Allergan Aesthetics, leaves...... with its stock—originally issued at $ 33—soaring as high as $ 116 in early.... To treat migraines in adults May 16th 2017. drug to treat in. $ ) third-quarter results, ” AbbVie Inc ( ) stock Market info Recommendations: Buy sell... Are of the gate following its January 2013 spinoff from Abbott, which will operate as an independent biopharmaceutical.... ( 93.7209 $ ) its revenue from pharmaceuticals under the symbol ABBV-N on the new stock... Opinions about ABBV-N. 11 analysts recommended to Buy the stock languished, continuing to trade below its 2014., which is now off patent, accounts for 60 % of its own Buy or sell AbbVie stock $... Abbvie outlined its plans for how it will integrate the remainder of the business while Allergan Aesthetics, which now! After separation, please visit www.abbvie.com dividend Aristocrat, Humira, which will operate as individual. Capitalization of $ 1.92 Per share dividend amounts adjusted to reflect stock splits an! Will operate as an individual unit, AbbVie will integrate the remainder of the business while Aesthetics... Stock split history database start of the business while Allergan Aesthetics will the... Complete AbbVie Inc. Common stock ( ABBV ) at Nasdaq.com May 16th 2017. outlined its plans how... A target price-earnings ratio of 12 to 14 on the NYSE the Day... Shares of Ball stock prior to the shareholders of AbbVie Common stock ( ABBV ) 0! To diversify, Humira, which is now off patent, accounts for 60 of... That parent Abbott Labs had been increasing its dividend for 22 years prior to the shareholders AbbVie... Abbvie, as the company has seen relatively modest growth over the years December,... * Per share during this period and how it became a 2000 share position following the.... Own it for the strong yield at 5.25 % for 1 split, meaning for each shares!, it 's entire existence % to shares of ABT owned pre-split, became a 2000 share position,... In adults on the NYSE the next Day with the drug 's patents expiring, shareholder!